ReviewThe Lancet. Infectious diseases2004
Epidemiological and genetic analysis of severe acute respiratory syndrome.
Review in The Lancet. Infectious diseases, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
53 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Incubation periods of acute respiratory viral infections: a systematic review.The Lancet. Infectious diseases · 2009Pooled it
- Integrating mathematical modelling and artificial intelligence to combat emerging viral syndemics: A systematic review.New microbes and new infections · 2026Review
- The Gut Microbiome in Enteric Viral Infections: Underlying Mechanisms and Therapeutic Approaches.Microorganisms · 2025Review
- Theoretical Epidemiology Needs Urgent Attention in China.China CDC weekly · 2024Article
- Gastrointestinal tract and viral pathogens.World journal of virology · 2023Review
- Assessment of transmissibility and measures effectiveness of SARS in 8 regions, China, 2002-2003.Frontiers in cellular and infection microbiology · 2023Article
- Editorial: Cellular Mechanisms of Aging and Longevity in Oral Health and Disease.Frontiers in oral health · 2022Article
- Molecular adaptive evolution of SARS-COV-2 spike protein in Saudi Arabia.Saudi journal of biological sciences · 2021Article
- Circulation of human coronaviruses OC43 and 229E in Córdoba, Argentina.Archives of virology · 2021Observational
- Comparative Transcriptome Profiling of Human and Pig Intestinal Epithelial Cells after Porcine Deltacoronavirus Infection.Viruses · 2021Article
- Evolution and genetic diversity of SARS-CoV-2 in Africa using whole genome sequences.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021Article
- Analyzing left-truncated and right-censored infectious disease cohort data with interval-censored infection onset.Statistics in medicine · 2021Article
- Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches.ImmunoTargets and therapy · 2021Review
- Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges.Life sciences · 2020Article
- Do pets protect their owners in the COVID-19 era?Medical hypotheses · 2020Review
- Active case finding with case management: the key to tackling the COVID-19 pandemic.Lancet (London, England) · 2020Review
- COVID-19: Immunology and treatment options.Clinical immunology (Orlando, Fla.) · 2020Review
- Comparison of third-generation sequencing approaches to identify viral pathogens under public health emergency conditions.Virus genes · 2020Article
- Is COVID-19 receiving ADE from other coronaviruses?Microbes and infection · 2020Article
- Coronavirus disease 2019 (COVID-19) outbreak: Could pigs be vectors for human infections?Xenotransplantation · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The severe acute respiratory syndrome (SARS) epidemics in 2002-2003 showed how quickly a novel infectious disease can spread both within communities and internationally. We have reviewed the epidemiological and genetic analyses that have been published both during and since these epidemics, and show how quickly data were collected and analyses undertaken. Key factors that determine the speed and scale of transmission of an infectious disease were estimated using statistical and mathematical modelling approaches, and phylogenetic analyses provided insights into the origin and evolution of the SARS-associated coronavirus. The SARS literature continues to grow, and it is hoped that international collaboration in the analysis of epidemiological and contact-network databases will provide further insights into the spread of this newly emergent infectious disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.